Literature DB >> 6730856

The prevalence and progression of autoimmune thyroid disease in the elderly.

J H Lazarus, M L Burr, A M McGregor, A P Weetman, M Ludgate, J S Woodhead, R Hall.   

Abstract

Thyroid antibodies were measured by an enzyme-linked assay system (ELISA) on a random sample of 414 asymptomatic elderly people aged 70 years or more in a South Wales town in 1977. The prevalence of elevated titres of microsomal antibodies was 15.4% and of thyroglobulin antibodies 13.3%; 8.5% had an elevation of both antibodies. Five years later thyroid function was evaluated in 51 (66.6%) of those people with raised antibody titres in 1977 and compared with a control group of 46 old people drawn from the original population. Significant fluctuations of microsomal and thyroglobulin antibody titres were observed in two thirds of the antibody positive group. Three people in the control group developed positive thyroid antibodies during this period. Only 1 person in the antibody positive group became hypothyroid. The prognostic significance of raised thyroid antibodies with or without elevated TSH levels is less in the elderly than in middle aged or younger people. The significance of the fluctuating antibody levels as measured by a more sensitive method remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6730856     DOI: 10.1530/acta.0.1060199

Source DB:  PubMed          Journal:  Acta Endocrinol (Copenh)        ISSN: 0001-5598


  8 in total

Review 1.  Management of the unexpected result: compensated hypothyroidism.

Authors:  R Benediktsson; A D Toft
Journal:  Postgrad Med J       Date:  1998-12       Impact factor: 2.401

2.  A patient with hepatitis B, antimicrosomal antibodies, and autoimmune hypothyroidism.

Authors:  W R Catapani; O Valente; C Aguiar
Journal:  Postgrad Med J       Date:  1996-12       Impact factor: 2.401

Review 3.  Mechanisms of age-related endocrine alterations. Part II.

Authors:  A D Mooradian
Journal:  Drugs Aging       Date:  1993 Mar-Apr       Impact factor: 3.923

4.  HLA-DR3 and HLA-DR5 confer risk for autoantibody positivity against the thyroperoxidase (mic-TPO) antigen in healthy blood donors.

Authors:  B O Boehm; P Kühnl; C Löliger; U Ketzler-Sasse; G Holzberger; S Seidl; R Bäuerle; E Schifferdecker; K H Usadel
Journal:  Clin Investig       Date:  1993-03

Review 5.  Clinical use of sensitive assays for thyroid-stimulating hormone.

Authors:  P A Masters; R J Simons
Journal:  J Gen Intern Med       Date:  1996-02       Impact factor: 5.128

6.  Human lymphocyte antigens (HLA) and Graves' disease in Turkey.

Authors:  Y Orhan; A Azezli; M Carin; F Aral; E Sencer; S Molvalilar
Journal:  J Clin Immunol       Date:  1993-09       Impact factor: 8.317

7.  Enhanced cellular proliferative activity and cell death in chronic thyroiditis and thyroid papillary carcinoma.

Authors:  I Okayasu; M Saegusa; M Fujiwara; Y Hara; N R Rose
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

8.  Clinical and Immunological Aspects in Hashimoto's Thyroiditis.

Authors:  Adriana Rosca; Victor Dumitrascu; Daniela Grecu; Ioana Zosin; Mihaela David
Journal:  EJIFCC       Date:  2003-12-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.